ARCADIA BIOSCIENCES INC (RKDA) Stock Fundamental Analysis
NASDAQ:RKDA - Nasdaq - US0390143032 - Common Stock - Currency: USD
We assign a fundamental rating of 4 out of 10 to RKDA. RKDA was compared to 89 industry peers in the Food Products industry. No worries on liquidiy or solvency for RKDA as it has an excellent financial health rating, but there are worries on the profitability. RKDA shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
RKDA had negative earnings in the past year.
RKDA had a negative operating cash flow in the past year.
RKDA had negative earnings in each of the past 5 years.
RKDA had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
RKDA has a Return On Assets of -15.52%. This is in the lower half of the industry: RKDA underperforms 79.78% of its industry peers.
RKDA has a Return On Equity of -22.64%. This is in the lower half of the industry: RKDA underperforms 73.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.52% | ||
| ROE | -22.64% | ||
| ROIC | N/A |
ROA(3y)-58.73%
ROA(5y)-43.88%
ROE(3y)-98.37%
ROE(5y)-71.81%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
RKDA has a Gross Margin of 42.57%. This is amongst the best in the industry. RKDA outperforms 98.88% of its industry peers.
In the last couple of years the Gross Margin of RKDA has grown nicely.
RKDA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 42.57% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.63%
GM growth 5Y13.12%
2. Health
2.1 Basic Checks
RKDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RKDA has more shares outstanding
The number of shares outstanding for RKDA has been increased compared to 5 years ago.
There is no outstanding debt for RKDA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
Based on the Altman-Z score of -29.39, we must say that RKDA is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -29.39, RKDA is not doing good in the industry: 93.26% of the companies in the same industry are doing better.
RKDA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -29.39 |
ROIC/WACCN/A
WACC9.8%
2.3 Liquidity
RKDA has a Current Ratio of 3.99. This indicates that RKDA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of RKDA (3.99) is better than 92.13% of its industry peers.
RKDA has a Quick Ratio of 3.41. This indicates that RKDA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.41, RKDA belongs to the best of the industry, outperforming 94.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.99 | ||
| Quick Ratio | 3.41 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 82.24% over the past year.
The Revenue has grown by 9.40% in the past year. This is quite good.
RKDA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.95% yearly.
EPS 1Y (TTM)82.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%206.74%
Revenue 1Y (TTM)9.4%
Revenue growth 3Y-9.38%
Revenue growth 5Y33.95%
Sales Q2Q%-4.38%
3.2 Future
The Earnings Per Share is expected to grow by 23.95% on average over the next years. This is a very strong growth
RKDA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.49% yearly.
EPS Next Y98.82%
EPS Next 2Y23.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year28%
Revenue Next 2Y26.49%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
RKDA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RKDA. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
RKDA's earnings are expected to grow with 23.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.95%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for RKDA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:RKDA (6/5/2025, 8:06:54 PM)
4.79
+0.17 (+3.68%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners10.76%
Inst Owner Change-2.61%
Ins Owners0.46%
Ins Owner Change0.01%
Market Cap6.56M
Analysts82.86
Price Target12.24 (155.53%)
Short Float %1.42%
Short Ratio1.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)30.35%
Min EPS beat(2)-229.37%
Max EPS beat(2)290.08%
EPS beat(4)1
Avg EPS beat(4)-8.19%
Min EPS beat(4)-229.37%
Max EPS beat(4)290.08%
EPS beat(8)5
Avg EPS beat(8)11.81%
EPS beat(12)8
Avg EPS beat(12)10.58%
EPS beat(16)12
Avg EPS beat(16)16.16%
Revenue beat(2)0
Avg Revenue beat(2)-5.08%
Min Revenue beat(2)-9.5%
Max Revenue beat(2)-0.65%
Revenue beat(4)2
Avg Revenue beat(4)8.99%
Min Revenue beat(4)-9.5%
Max Revenue beat(4)38.42%
Revenue beat(8)4
Avg Revenue beat(8)-2.4%
Revenue beat(12)5
Avg Revenue beat(12)-10.5%
Revenue beat(16)6
Avg Revenue beat(16)-7.62%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-3.95%
EPS NQ rev (3m)-3.95%
EPS NY rev (1m)97.87%
EPS NY rev (3m)97.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-1.54%
Revenue NY rev (3m)-1.54%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.25 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.74 | ||
| P/tB | 0.74 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.49
EYN/A
EPS(NY)-2.4
Fwd EYN/A
FCF(TTM)-5.85
FCFYN/A
OCF(TTM)-5.84
OCFYN/A
SpS3.84
BVpS6.5
TBVpS6.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.52% | ||
| ROE | -22.64% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 42.57% | ||
| FCFM | N/A |
ROA(3y)-58.73%
ROA(5y)-43.88%
ROE(3y)-98.37%
ROE(5y)-71.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.63%
GM growth 5Y13.12%
F-Score3
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 4% | ||
| Cap/Sales | 0.06% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.99 | ||
| Quick Ratio | 3.41 | ||
| Altman-Z | -29.39 |
F-Score3
WACC9.8%
ROIC/WACCN/A
Cap/Depr(3y)10.16%
Cap/Depr(5y)96.24%
Cap/Sales(3y)0.38%
Cap/Sales(5y)9.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%206.74%
EPS Next Y98.82%
EPS Next 2Y23.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.4%
Revenue growth 3Y-9.38%
Revenue growth 5Y33.95%
Sales Q2Q%-4.38%
Revenue Next Year28%
Revenue Next 2Y26.49%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y43.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year9.91%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y36.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.27%
OCF growth 3YN/A
OCF growth 5YN/A